Tumor heterogeneity: The challenge of precision medicine

Progress in Biochemistry and Biophysics

Volumn 42, Issue 10, 2015, Pages 881-890

  Tu, Chao Feng ^a   Qi, Peng ^a   Li, Xia Yu ^a   Mo, Yong Zhen ^a   Li, Xiao Ling ^a   Xiong, Wei ^a   Zeng, Zhao Yang ^a   Li, Gui Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Heterogeneity; Precision medicine; Tumor

Indexed keywords

EID: 84960109823     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.16476/j.pibb.2015.0214     Document Type: Review

References (85)

1. Melo F D S E, Vermeulen L, Fessier E, et al. Cancer heterogeneity-a multifaceted view. EMBO Reports, 2013, 14(8): 686-695
2. Marjanovic N D, Weinberg R A, Chaffer C L. Cell plasticity and heterogeneity in cancer. Clin Chem, 2013, 59(1): 168-179
3. Navin N.E. Tumor evolution in response to chemotherapy: phenotype versus genotype. Cell Rep, 2014, 6(3): 417-419
4. Gerlinger M, Horswell S, Larkin J, et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet, 2014, 46(3): 225-233
5. Sottoriva A, Spiteri I, Piccirillo S G, et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA, 2013, 110(10): 4009-4014
6. Almendro V, Marusyk A, Polyak K. Cellular heterogeneity and molecular evolution in cancer. Annu Rev Pathol, 2013, 8: 277-302
7. Chin F Y, Leung H C, Yiu S M. Sequence assembly using next generation sequencing data-challenges and solutions. Sci China Life Sci, 2014, 57(11): 1140-1148
8. Gao Y, Xie B, Liu R. Delivering noninvasive prenatal testing in a clinical setting using semiconductor sequencing platform. Sci China Life Sci, 2014, 57(7): 737-738
9. Cao X. Whole genome sequencing of cotton-a new chapter in cotton genomics. Sci China Life Sci, 2015, 58(5): 515-516
10. Hu W, Chen J. Whole-genome sequencing opens a new era for molecular breeding of grass carp (Ctenopharyngodon idellus). Sci China Life Sci, 2015, 58(6): 619-620
11. Wang Y, Ding Y, Yu D, et al. High-throughput sequencing-based genome-wide identification of microRNAs expressed in developing cotton seeds. Sci China Life Sci, 2015, 58(8): 778-786
12. Xie Q, Cao Y, Su J, et al. Genomic sequencing and analysis of the first imported Middle East Respiratory Syndrome Coronavirus (MERS CoV) in China. Sci China Life Sci, 2015, 58(8): 818-820
13. Chen G, Shi T. Next-generation sequencing technologies for personalized medicine: promising but challenging. Sci China Life Sci, 2013, 56(2): 101-103
14. Wu C, Kraft P, Zhai K, et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet, 2012, 44(10): 1090-1097
15. Abnet C C, Freedman N D, Hu N, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet, 2010, 42(9): 764-767
16. Wang L D, Zhou F Y, Li X M, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet, 2010, 42(9): 759-763
17. Wu C, Hu Z, He Z, et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet, 2011, 43(7): 679-684
18. Wu C, Wang Z, Song X, et al. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nat Genet, 2014, 46(9): 1001-1006
19. Zeng Z, Huang H, Zhang W, et al. Nasopharyngeal carcinoma: advances in genomics and molecular genetics. Sci China Life Sci, 2011, 54(10): 966-975
20. Zeng Z, Fan S, Zhang X, et al. Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma. Clin Transi Oncol, 2015 Aug 11
21. Feng B J, Huang W, Shugart Y Y, et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet, 2002, 31(4): 395-399
22. Bei J X, Li Y, Jia W H, et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet, 2010, 42(7): 599-603
23. Xiong W, Zeng Z Y, Xia J H, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res, 2004, 64(6): 1972-1974
24. Zeng Z, Zhou Y, Zhang W, et al. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med, 2006, 8(3): 156-160
25. Zhang W, Fan S, Zou G, et al. Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma. Tumour Biol, 2015, 36(2): 675-683
26. Zhou Y, Zeng Z, Zhang W, et al. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer, 2008, 123(9): 2065-2072
27. Huang H B, Deng M, Zheng Y, et al. Innate immune protein lactotransferrin prevents initiation and arrests progression of nasopharyngeal carcinoma. Prog Biochem Biophys, 2013, 40(4): 319-324
28. Zhou Y, Wang W, Zheng D, et al. Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes. Med Oncol, 2012, 29(3): 1456-1462
29. Lu C C, Chen J C, Tsai S T, et al. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping. Int J Cancer, 2005, 115(5): 742-746
30. Li Z, Wang L, Zhang X, et al. Chinese Journal of Medical Genetics, 2001, 18(5): 338-342
31. Fang Y, Guan X, Guo Y, et al. Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Genes Chromosomes Cancer, 2001, 30(3): 254-260
32. Hui A B, Lo K W, Leung S F, et al. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation. Int J Cancer, 1999, 82(4): 498-503
33. Chen Y J, Ko J Y, Chen P J, et al. Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization. Genes Chromosomes Cancer, 1999, 25(2): 169-175
34. Baca S C, Prandi D, Lawrence M S, et al. Punctuated evolution of prostate cancer genomes. Cell, 2013, 153(3): 666-677
35. Dalerba P, Kalisky T, Sahoo D, et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nature Biotechnology, 2011, 29(12): 1120-1127
36. Zhang J, Fujimoto J, Wedge D C, et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science, 2014, 346(6206): 256-259
37. Wang Y, Waters J, Leung M L, et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature, 2014, 512(7513): 155-160
38. Liu Z Q, Tian Y Q, Hu Y F, et al. Alteration of gene expression during nasopharyngeal carcinogenesis revealed by oligonucleotide microarray after microdissection of tumor tissue and normal epithelia from nasopharynx. Chin Med J (Engl), 2009, 122(4): 437-443
39. Zeng Z, Zhou Y, Xiong W, et al. Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol, 2007, 133(2): 71-81
40. Zeng Z Y, Zhou Y H, Zhang W L, et al. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol, 2007, 38(1): 120-133
41. Zhou Y, Zeng Z, Zhang W, et al. Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization. Eur J Cancer Prev, 2008, 17(6): 561-571
42. Zhang W, Zeng Z, Zhou Y, et al. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Biophys Sin (Shanghai), 2009, 41(5): 414-428
43. Zhang W, Zeng Z, Fan S, et al. Evaluation of the prognostic value of TGF-beta superfamily type I receptor and TGF-beta type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays. J Mol Histol, 2012, 43(3): 297-306
44. Zhang W, Huang C, Gong Z, et al. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol, 2013, 44(5): 545-554
45. Gong Z, Zhang S, Zeng Z, et al. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. PLoS One, 2014, 9(11): e110674
46. Liao Q, Zeng Z, Guo X, et al. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene, 2014, 33(16): 2098-2109
47. Zeng Z, Huang H, Huang L, et al. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci China Life Sci, 2014, 57(3): 315-326
48. Bo H, Gong Z, Zhang W, et al. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget, 2015, 6(24): 20404-20418
49. Li Y W, Wang Y M, Zhang X Y, et al. Progress of long noncoding RNA HOTAIR in human cancer. Prog Biochem Biophys, 2015, 42(3): 228-235
50. Yang Y, Umetsu J, Lu Z J. Global signatures of protein binding on structured RNAs in Saccharomyces cerevisiae. Sei China Life Sei, 2014, 57(1): 22-35
51. Reis-Filho J S, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. The Lancet, 2011, 378(9805): 1812-1823
52. Losi L, Baisse B, Bouzourene H, et al. Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis, 2005, 26(5): 916-922
53. Zhang B, Wang J, Wang X, et al. Proteogenomic characterization of human colon and rectal cancer. Nature, 2014, 513(7518): 382-387
54. Cvitkovic E, Bachouchi M, Armand J. Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications. Hematology/ Oncology Clinics of North America, 1991, 5(4): 821-838
55. Tang A, Li N, Li X, et al. Dynamic activation of the key pathways: linking colitis to colorectal cancer in a mouse model. Carcinogenesis, 2012, 33(7): 1375-1383
56. Wang W, Li X, Zheng D, et al. Dynamic changes of peritoneal macrophages and subpopulations during ulcerative colitis to metastasis of colorectal carcinoma in a mouse model. Inflamm Res, 2013, 62(7): 669-680
57. Huang H B, Liang F, Xiong W, et al. Bioinformatics accelerates drug repositioning. Prog Biochem Biophys, 2012, 39(1): 35-44
58. Gerlinger M, Rowan A J, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med, 2012, 366(10): 883-892
59. Shibata D. Cancer. Heterogeneity and tumor history. Science, 2012, 336(6079): 304-305
60. Almendro V, Kim H J, Cheng Y K, et al. Genetic and phenotypic diversity in breast tumor metastases. Cancer Res, 2014, 74(5): 1338-1348
61. Yates L R, Gerstung M, Knappskog S, et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Med, 2015, 21(7): 751-759
62. Ding L, Ley T J, Larson D E, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature, 2012, 481(7382): 506-510
63. Anderson K, Lutz C, Van Delft F W, et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature, 2011, 469(7330): 356-361
64. Notta F, Mullighan C G, Wang J C, et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature, 2011, 469(7330): 362-367
65. Patel A P, Tirosh I, Trombetta J J, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science, 2014, 344(6190): 1396-1401
66. Buob D, Fauvel H, Buisine M-P, et al. The complex intratumoral heterogeneity of colon cancer highlighted by laser microdissection. Digestive Diseases and Sciences, 2012, 57(5): 1271-1280
67. Brocks D, Assenov Y, Minner S, et al. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. Cell Rep, 2014, 8(3): 798-806
68. Gong Z J, Huang H B, Xu K, et al. Advances in microRNAs and TP53 gene regulatory network. Prog Biochem Biophys, 2012, 39(12): 1133-1144
69. Patel A P, Tirosh I, Trombetta J J, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science, 2014, 344(6190): 1396-1401
70. Tang K, Wei F, Bo H, et al. Cloning and functional characterization of a novel long non-coding RNA gene associated with hepatocellular carcinoma. Prog Biochem Biophys, 2014, 41(2): 153-162
71. Nowell P.C. The clonal evolution of tumor cell populations. Science, 1976, 194(4260): 23-28
72. Pietras A. Cancer stem cells in tumor heterogeneity. Adv Cancer Res, 2011:112255-112281
73. Campbell L L, Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution?. Cell Cycle, 2007, 6(19): 2332-2338
74. Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta, 2010, 1805(1): 105-117
75. Durrert R, Foo J, Leder K, et al. Intratumor heterogeneity in evolutionary models of tumor progression. Genetics, 2011, 188(2): 461-477
76. Visvader J E, Lindeman G J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell, 2012, 10(6): 717-728
77. Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res, 2012, 72(19): 4875-4882
78. Baca S C, Prandi D, Lawrence M S, et al. Punctuated evolution of prostate cancer genomes. Cell, 2013, 153(3): 666-677
79. Shah S P, Roth A, Goya R, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature, 2012, 486(7403): 395-399
80. Vaziri S A, Tavares E J, Golshayan A R, et al. Differing von hippel lindau genotype in paired primary and metastatic tumors in patients with clear cell renal cell carcinoma. Front Oncol, 2012, 2: 51
81. Shipitsin M, Campbell L L, Argani P, et al. Molecular definition of breast tumor heterogeneity. Cancer cell, 2007, 11(3): 259-273
82. Mora J, Cheung N L, Gerald K. Generic heterogeneity and clonal evolution in neuroblastoma. Br J Cancer, 2001, 85(2): 182-189
83. Navin N, Kendall J, Troge J, et al. Tumour evolution inferred by single-cell sequencing. Nature, 2011, 472(7341): 90-94
84. Hyman D M, Puzanov I, Subbiah V, et al. Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations. N Engl J Med, 2015, 373(8): 726-736
85. Schwaederle M, Daniels G A, Piccioni D E, et al. On the road to precision cancer medicine: analysis of genomic biomarker actionability in 439 patients. Mol Cancer Ther, 2015, 14(6): 1488-1494